Tue, November 14, 2017
Mon, November 13, 2017
Fri, November 10, 2017
Thu, November 9, 2017
Wed, November 8, 2017
Tue, November 7, 2017
Mon, November 6, 2017
Fri, November 3, 2017

David Buck Maintained (SUPN) at Strong Buy with Decreased Target to $50 on, Nov 8th, 2017


//stocks-investing.news-articles.net/content/201 .. with-decreased-target-to-50-on-nov-8th-2017.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


David Buck of B. Riley Securities, Maintained "Supernus Pharmaceuticals, Inc." (SUPN) at Strong Buy with Decreased Target from $53 to $50 on, Nov 8th, 2017.

David has made no other calls on SUPN in the last 4 months.



There are 2 other peers that have a rating on SUPN. Out of the 2 peers that are also analyzing SUPN, all agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • David Amsellem of "Piper Sandler" Downgraded from Buy to Hold on, Monday, July 17th, 2017
  • Ken Trbovich of "Janney Montgomery Scott" Initiated at Hold and Held Target at $47 on, Friday, July 14th, 2017

Publication Contributing Sources